SEC Filing Details

Document Details

Form
3
Filing Date
Apr 22, 2020
Document Date
Apr 16, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.
Filer
BHAVNAGRI VEER